2020 CRI Meeting Abstracts

The 12th Annual AACI CRI Meeting will focus on the future of cancer clinical research. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers. Questions about abstracts can be directed to Program Manager Kate Shaw at kathryn@aaci-cancer.org.

Abstract Reviews
This year, AACI received 77 abstract submissions. Abstract reviews are ongoing, and authors will be notified later this month of abstracts selected for virtual presentation. Any changes to this schedule will be communicated to abstract authors. Abstracts selected for a virtual presentation will be featured on a live panel and Q&A session on July 8. 

Concurrent Poster Session
Additionally, AACI will recognize seven abstracts to be presented as part of a virtual poster session. The poster session provides the opportunity for abstract authors to inform meeting attendees about CTO challenges and solutions implemented at AACI cancer centers where one poster from each abstract submission category will be selected.  
 
Virtual Meeting Poster Submission
All abstract authors are encouraged to submit a poster to highlight their findings on the virtual meeting app. Additionally, posters will be featured in the AACI CRI abstract book published later this year. Information about the poster specifications can be found on the Call for Abstracts page. The deadline for submitting posters has been extended to 5:00 pm Pacific time on Monday, June 8.

Digital Presentation
In addition to submitting a poster, all authors are invited to submit a brief, pre-recorded digital presentation. Digital presentations will be featured on the virtual meeting app. 

Abstracts are organized by category, in alphabetical order by cancer center. 

Categories:
Clinical Research Operations
Finance/CCSG/PRMS
Investigator-Initiated Trials
Regulatory
Training & Quality Assurance
Trial Recruitment & Community Outreach and Engagement
Trial Start-up and Activation

 

Clinical Research Operations
1. Metropolitan Management of Mitten-wide Clinical Trials: Coordination From Our Own Backyard [Abstract
J. Ventimiglia, E. Doppel, B. Olsen
Barbara Ann Karmanos Cancer Institute, Wayne State University

2. The Dog Ate My Pill Diary and Other Stories From the Frontlines of Drug Accountability [Abstract
C. Galasso, B. Dickow, C. Houde, J. Ventimiglia, M. Ventimiglia, C. Zack, C. Zuccaro
Barbara Ann Karmanos Cancer Institute, Wayne State University

3. Centralized Research Patient Scheduling & Authorizations [Abstract
R. Chiechi, P. Herena, M. Kenney, B. Williams, M. Licata
City of Hope Comprehensive Cancer Center

4. Research Operations Innovation Program [Abstract
R. Chiechi, S. Rosen, A. Lee, M. Licata, M. Kenney, A. Hammond, M. Bush, J. Light
City of Hope Comprehensive Cancer Center

5. Operationalizing Protocols Through Treatment Plan Guidelines [Abstract
M. Licata, C. Krygsman, P. Mack, A. Chung, A. Yi, A. Lee, R. Chiechi, P. Herena, B. Williams
City of Hope Comprehensive Cancer Center 

6. Moving Cellular Therapy Clinical Trials in the Outpatient Setting: Aligning With Institutional Standards and FACT [Abstract
P. Herena, M. Licata, B. Williams, C. Krygsman, R. Chiechi, A. Lee, M. Shields, A. Chung
City of Hope Comprehensive Cancer Center

7. Improving Staff Engagement and Retention Through a Staff Engagement Committee and Subsequent Collaboration Between Staff and Management [Abstract
A. Toth, K. Grimaldi, C. Light, N. Ross, S. Zamora, D. Cohen, E. Love
Laura and Isaac Perlmutter Cancer Center at NYU Langone

8. Optimizing Clinical Trial Conduct for CAR T Therapies Improves Trial Efficiency [Abstract
J. Bruggeman, G. Bouska, K. Croghan, C. Grimont, M. Burt, C. DuBois, Y. Lin
Mayo Clinic Cancer Center

9. One Small Step: Eliminating Investigator Sign-offs on Individual Epic Lab Reports [Abstract
R. Selle, J. Thomas, B. Oleson
Medical College of Wisconsin Cancer Center 

10. Clinical Research Strategic Partnerships (CRSP) Program Initiatives and Future Goals [Abstract
S. Salvati, S. Yoon
Memorial Sloan Kettering Cancer Center

11. Optimizing Our Protocol Management System Data and Aiding Research Portfolio Decisions Through Use of Custom Dashboards [Abstract
J. Migliacci, B. Seko, A. Bijwe, S. Hanley, K. Kaufman, J. Lengfellner, R. Cambria, A. Rodavitch
Memorial Sloan Kettering Cancer Center 

12. Registering 100% of Clinical Trial Participants: How Memorial Sloan Kettering Ensures Registration Accountability [Abstract
R. Panchal, M. Buckley, B. Search, K.-H. Lin, D. Caron-Fabio, J. Yan, J. Lengfellner
Memorial Sloan Kettering Cancer Center

13. Staffing Model Reported Effort and Study Budgets: Are We In Sync? [Abstract
E. Siglinsky, S. Goksu, H. Phan, K. Crane, M. Beg, E. Williams
Simmons Comprehensive Cancer Center, UT Southwestern Medical Center 

14. Utilizing the Clinical Trial Management System (CTMS) to Batch Load Accrual Data to the Clinical Trials Reporting Program (CTRP) System [Abstract
M. Aguilar1, S. Antony1, E. Williams1, S. Nonemaker-Cox2
1Simmons Comprehensive Cancer Center, UT Southwestern Medical Center; 2Essex Management

15. Creating a Culture of Continuous Improvement in a Cancer Clinical Trials Office [Abstract
E. Anderson, Y. Pang, L. Craveiro, B. Hann, A. Nika
Stanford Cancer Institute 

16. New Study Feasibility: Harnessing the Power of REDCap [Abstract
M. Ashland, L. Craveiro
Stanford Cancer Institute

17. Conquering Resourcing [Abstract
B. Broome, D. Pal Mudaranthakam
The University of Kansas Cancer Center

18. Connecting the Chain – Part Two [Abstract
D. Pal Mudaranthakam1, J. Thompson1, D. Streeter1, R. Jensen1, M. Mayo1, A. Chahal2, S. Yadav2, J. McIlwain2
1The University of Kansas Cancer Center; 2nCoup Inc. 

19. Adverse Event Reporting System [Abstract
A. Annis, M. McAdoo, A. Hanlyn, Z. Feng, A. Smith, K. Simpson
UAMS Winthrop P. Rockefeller Cancer Institute

20. Arkansas-Patient Study Calendar [Abstract
K. Simpson, A. Annis, C. Golden, Z. Feng, A. Smith, K. Zorn
UAMS Winthrop P. Rockefeller Cancer Institute 

21. Using Video Remote Interpretation to Overcome Language Barriers With Non-English Speakers in Clinical Trials [Abstract
C. Garcia, J. Bourgeois, D. Harvey, C. Lewis
Winship Cancer Institute of Emory University

22. Winship Clinical Trials Office CAPA Review Process – CAPA Review Team [Abstract]
P. Bourbo, C. Sharp, K. Nguyen, T. Kurilo, M. Hananel
Winship Cancer Institute of Emory University

23. Piloting a "Just-in-Time" Model to Improve Efficiency and Accuracy in Phase I Clinical Trials Pharmacy Order Creation Process [Abstract
E. Judson-Barton, M. Williams, C. Belmore
Winship Cancer Institute of Emory University


Back to top

Finance/CCSG/PRMS

24. Capturing Metrics for the First Stage of Protocol Review at a Consortium Cancer Center [Abstract
K. Hoy1, A. Firstencel1, H.J. Pounardijian1, J. Chan1, K. Jenkins2, L. Mooney2, M. Kilbane2
1Case Comprehensive Cancer Center; 2Cleveland Clinic Cancer Center

25. Building the NCI Network Program [Abstract] 
L. Gaffney, J. Mohr, M. Warren, C. Aghajanian, P. Sabbatini, E. Cottington, L. Deen, B. Zakrzewski, J. Klinger, S. Dominguez, C. Houston
Memorial Sloan Kettering Cancer Center

26. Memorial Sloan Kettering’s Protocol Review Core: A Specialized Approach to Protocol Review Committee Management [Abstract
S. Hanley, J. Migliacci, C. Ryan, X. Lekperic, K. Napolitano, A. Rodavitch
Memorial Sloan Kettering Cancer Center

27. Time is Money: The Impact of Clinical Research Finance Centralization [Abstract
C. Sanford, B. Zakrzewski
Memorial Sloan Kettering Cancer Center

28. Utilizing OnCore Capabilities to Automate Annual Continuation Review Submissions to PRMC [Abstract
S. Phillips
Siteman Cancer Center

29. Building the Post-award Management Infrastructure and Process Support to Reduce Turnaround Time to Collect Study Invoice(s) for Sponsor Clinical Trials [Abstract
P. Chang
Stanford Cancer Institute

30. Clinical Research: Following the Money [Abstract]
C. Golden, A. Annis, L. Hutchins, D. Drum, R. Geary, A. Smith, Z. Feng, N. Pruss
UAMS Winthrop P. Rockefeller Cancer Institute

31. Revising an Institutional PRMC Charter to Achieve NCI Standards: Impacts, Efficiencies, and Potential for Further Improvement [Abstract
C. Vollmer, N. Kurtzweil, C. Allen, E. Kantemneni, T. Herzog
UC Cancer Center

32. Streamlining Feasibility Assessment Within the Scientific Review Process [Abstract
A. Anderson, A. Ivey, T. Guinn, T. George
University of Florida Health Cancer Center

33. An Approach to Revitalizing PRMS Scientific Progress Reviews [Abstract
S. Brogan, D. Martinez
Yale Cancer Center, Yale School of Medicine

Back to top

Investigator-Initiated Trials

34. The Sample Collection and Tracking Process for Multisite Investigator-Initiated Trials [Abstract
A. Bauchle, L. Sego
Indiana University Melvin and Bren Simon Cancer Center

35. Stimulating Investigator-Initiated Trial Development: A Comprehensive Approach to Provide Guidance, Mentorship, and Logistical Support for Principal Investigators [Abstract
A. Anshu, B. Oleson, B. Brito, M. Larson, A. Szabo, K. Marquardt, E. Gore, H. Rui, J. Thomas, B. Shaw, S. Wong
Medical College of Wisconsin Cancer Center

36. A Risk-Based Approach to Monitoring and Auditing Multicenter Investigator-Initiated Trials [Abstract
K. Muenkel, S. Hughes, J. Walkley, M. Warren, A. Granobles, F. Puma, S. Puleio, K. Yataghene, C. Houston
Memorial Sloan Kettering Cancer Center

37. Increasing Interventional Treatment IITs in the Study Start-up Pipeline With an IIT Committee Approach [Abstract
N. Kurtzweil, S. Palackdharry, M. Racic, T. Wise-Draper
UC Cancer Center

38. Investigator-Initiated Trials in the Wild, Wild West: Implementation of the Oncology Clinical Research Support Team at the University of Colorado Cancer Center [Abstract
S. Grolnic, T. Cull
University of Colorado Cancer Center

Back to top

Regulatory

39. Redesigning the Delegation of Authority Log for the Modern Cancer Center [Abstract
J. Wurth, T. Presley, J. Feola, A. Vogt, D. Bullock, D. Berkow
Masonic Cancer Center, University of Minnesota

40. MSKCC INDs Multicenter IITs: A Centralized Model in Regulatory Oversight [Abstract
H. Pham, W. Blouin, S. Yoon, J. Walkley, R. Ellis, M. Warren
Memorial Sloan Kettering Cancer Center

41. The Regulatory and Product Development Road to the Future of Cancer Care [Abstract
A. Yadav, R. Ellis, Z. Shabani, D.A. Ho, L. Shrestha, M. Varghese, H. Pham
Memorial Sloan Kettering Cancer Center

42. Electronic Regulatory Binders – A Homegrown System [Abstract
M. Kovak, D. Wade, B. Scanlon, B. Lehman, J. Holley, P. Newman, L. Hutchins, A. Annis
UAMS Winthrop P. Rockefeller Cancer Institute 

43. Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors [Abstract
L. Byatt1, K. Mileham2, S. Bruinooge3, C. Davis3, E. Garrett-Mayer3, P. Hurley3, L. Levit3, C. Schenkel3, M. Chuk4, A. Buchmeier5, R. Perez6, J. Vose7
1University of New Mexico Comprehensive Cancer Center; 2Levine Cancer Center, Atrium Health; 3American Society of Clinical Oncology; 4U.S. Food and Drug Administration; 5Sarah Cannon Research Institute; 6Bristol Myers Squibb; 7University of Nebraska Medical Center

Back to top

Training & Quality Assurance

44. Use of REDCap Database to Identify Trends in Non-compliance [Abstract
A. Kale, N. Cassim
City of Hope Comprehensive Cancer Center

45. The Case for Physician-Led Education Sessions for Research Coordinators [Abstract
L. Waitkus
Cleveland Clinic Cancer Center

46. Standardized and Personalized Training Results in Increased Job Satisfaction and a Reduction in Turnover [Abstract
K. Jenkins, J. Workman, L. Mooney, M. Kilbane
Cleveland Clinic Cancer Center

47. "Who Cares? It’s Just a Minimal Risk Study": The Case for Research Compliance Oversight of Cancer Population Sciences (CPS) Research [Abstract
E. Beck, K. Thorne
Huntsman Cancer Institute, University of Utah

48. Development of a Competence-Based Quality Assurance Program [Abstract
R. Kingsford, J. Espinosa, S. Sharry, J. Moehle, L. Lujan, T. Werner
Huntsman Cancer Institute, University of Utah

49. Advising and Trial Guidance for Investigators [Abstract
L. Sego, A. Bauchle, S. Edwards
Indiana University Melvin and Bren Simon Cancer Center

50. New Employee Orientation – Joining the 21st Century [Abstract
F. Kerr, M. Cheviron, S. Edwards, S. Asche
Indiana University Melvin and Bren Simon Cancer Center

51. Training the Masses –  Electronic Protocol Training [Abstract
J. Norfleet, F. Kerr, S. Asche, J. Nichols
Indiana University Melvin and Bren Simon Cancer Center

52. Approaching Goals With a Plan: Application of MSK Resources for Internal Audit Process Improvement [Abstract
C. Duarte
Memorial Sloan Kettering Cancer Center

53. Improving Clinical Research Quality and Efficiency Through the Implementation of a Risk-Based Audit Approach [Abstract
S. Puleio
Memorial Sloan Kettering Cancer Center

54. Expanding the Scope of an Internal Quality Assurance Program to Initiate Change on a Mezzo- and Macro-level [Abstract
E. Harms, N. Borror, K. Williams
Siteman Cancer Center

55. A Process for the People: Updating Oral Medication Compliance Policy, Guidelines, and Tools [Abstract
N. Borror, E. Harms, K. Williams, L. Menne
Siteman Cancer Center

56. Protocol-Specific Training in a Commercial IRB World: Adjusting the Process to Ensure Training Keeps Up [Abstract
L. Menne, E. Harms, N. Borror
Siteman Cancer Center

57. UF Health Cancer Center (UFHCC) Research Fantasy League: A Novel Approach to Employee Engagement [Abstract
T. Guinn, A. Anderson, A. Ivey, R. Houlihan
University of Florida Health Cancer Center

58. Minimizing Clinical Trial Deviations Through Lean Six Sigma and a CRO Compliance Committee [Abstract]
A. Barkman, T. Cummings, J. Kessler
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

59. Research Staff Orientation and Training [Abstract
M. Horak, D. Cleary, B. Pappu
UPMC Hillman Cancer Center

60. Development of an Integrated Orientation Program Using the Joint Task Force Core Competencies for Research Professionals [Abstract
E. Gainey, G. Beals
Vanderbilt-Ingram Cancer Center

61. Let It Go! One Strategy to Maximize Limited QA Resources [Abstract
A. Gateman, E. Smas
Yale Cancer Center, Yale School of Medicine

Back to top

Trial Recruitment & Community Outreach and Engagement 

62. Crack the Walnut! How Community Outreach Research Coordinators Can Empower African American Men to Come Out of Their Shell to Make an Informed Decision About Prostate Cancer Screening, a Cancer Prevention Project [Abstract
C. Chapman, K. Hunt, E. Meisler, D. Allen, S. Abraksia, A. Seals, N. Anderson, K. Sanders
Cleveland Clinic Cancer Center

63. Completing the Circle: Lay Summary of Protocol Results for Study Participants [Abstract]
V. Santana, D. Wallace, D. McGarry, E. Walker, L. Tanner, J. English
Comprehensive Cancer Center, St. Jude Children's Research Hospital

64. A Quick Guide to Affiliate and Satellite Site Activation and Oversight Process [Abstract]
G. Nachaegari
Huntsman Cancer Institute, University of Utah

65. The Challenges and Successes of Enrolling Participants on the Tomosynthesis Mammographic Imaging Screening Trial (TMIST or study EA1151) in Hawaii’s Minority/Underserved NCI Community Oncology Research Program (M/U NCORP) [Abstract]
S. Cheng1, S. Wakuk1, S. Lieu1, N. Ramos1, K. Bryant-Greenwood1, K. Cassel1, J. Berenberg1, M. Ka’aihue2, R. Lee2, E. Capps2
1University of Hawai'i Cancer Center, University of Hawai'i at Mānoa; 2Queen's Medical Center 

66. The Reinvigoration of Alliance Membership and Accrual: From Almost Losing Membership to a High-Performing Site in 2 Years
[Abstract
M. Russell, D. Kitterman, O. Danciu, J. Quigley
University of Illinois Cancer Center

67. Minority Accrual to Therapeutic Clinical Trials [Abstract]
M. Russell, D. Kitterman, O. Danciu
University of Illinois Cancer Center

Back to top

Trial Start-up and Activation

68. The Road to 90 [Abstract
M. Kelley, K. Donahue, M. Gorno, S. Bigelow, R. Jarrard, P. Dykema, R. George, V. Davis, V. Gorden
Barbara Ann Karmanos Cancer Institute, Wayne State University

69. Sponsor and Collaborator Content Management System [Abstract]
G. Balagot, N. Cassim
City of Hope Comprehensive Cancer Center

70. Redefining Clinical Trial Start-up Through Continuous Improvement [Abstract
L. Mooney, A. McCorkle, M. Kilbane
Cleveland Clinic Cancer Center

71. Improving Study Start-up Timelines: A Comprehensive, Multidisciplinary, Process-Improvement Initiative [Abstract
S. Skendzel, E. Orcholski, D. Krishnadas, R. Nicklow, M. Lindemann, M. Morris, J. Bruan
Masonic Cancer Center, University of Minnesota

72. Enhancing Productivity: Utilizing the ONBASE Application and Pharmacist Created Order Sets to Streamline the Trial Launch Process [Abstract
B. Secor, I. Reveles, D. Yzquierdo, A Rodriguez, M. Nashawati, M. Tomasini, P. Manea
Mays Cancer Center, UT Health San Antonio

73. Clinical Trials Time to Activation: The Process, Structure, and People [Abstract
Y. Suri, M. El Shayeb
O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham

74. C3OD User Interface – A Simple and Intuitive Solution to Feasibility Analysis for Clinical Trials [Abstract
D. Pal Mudaranthakam, J. Thompson, D. Streeter
The University of Kansas Cancer Center

75. Time to Activation: Are We Comparing Apples to Apples? [Abstract
A. Skafel, K. Shumate
UCSF Helen Diller Family Comprehensive Cancer Center

76. Reducing Burdens of Site Feasibility Assessments for Conducting Clinical Trials [Abstract
L. Byatt1, P. Hurley2, C. Davis2, J. Hofacker3, E.S. Kim4, D.M. Waterhouse5, G.S. Nowakowski6, D. Kurbegov7
1University of New Mexico Comprehensive Cancer Center; 2American Society of Clinical Oncology; 3Association of American Cancer Institutes; 4Levine Cancer Institute, Atrium Health; 5Oncology Hematology Care, Inc.; 6Mayo Clinic Cancer Center; 7Sarah Cannon Research Institute

77. Automatic Study Cost-Outs: A Tool Designed to Objectively Assess Trial Operations Costs for More Standardized and Efficient Budget Negotiations While Improving Overall Study Time to Activation [Abstract]
J. Plassmeyer, M. Yarkowski, G. Hickman, B. Crocker, K. Richter, K. Yee
UPMC Hillman Cancer Center

Back to top